CDH1 and colorectal carcinoma: When it comes to comparing E-cadherin levels within the CRC group between the metastasized and non-metastasized patients, we found a loss in E-cadherin expression in the CRC-metastatic group than the CRC-nonmetastatic one (p = 0.0049).